The Effect of Losartan and Amlodipine on Left Ventricular Diastolic Function and Atherosclerosis in Japanese Patients with Mild-to-Moderate Hypertension (J-ELAN) study

被引:23
作者
Yamamoto, Kazuhiro [1 ,2 ]
Ozaki, Hitoshi [3 ]
Takayasu, Ken [4 ]
Akehi, Noriyuki [5 ]
Fukui, Sugao [6 ]
Sakai, Akihiko [7 ]
Kodama, Mineo [8 ]
Shimonagata, Tsuyoshi [9 ]
Kobayashi, Keiji [10 ]
Ota, Mitsushige [11 ]
Horiguchi, Yasunori [12 ]
Ebisuno, Shoji [13 ]
Katsube, Yoshiki [14 ]
Yamazaki, Tsutomu [15 ]
Ohtsu, Hiroshi [16 ]
Hori, Masatsugu [1 ]
机构
[1] Osaka Univ, Grad Sch Med, Dept Cardiovasc Med, Suita, Osaka 5650871, Japan
[2] Osaka Univ, Ctr Adv Med Engn & Informat, Suita, Osaka 5650871, Japan
[3] Ozaki Clin, Higashiosaka, Osaka, Japan
[4] Takayasu Clin, Sakai, Osaka, Japan
[5] Settsuiseikai Hosp, Settsu, Japan
[6] Kawasaki Hosp, Kaizuka, Japan
[7] Sakai Clin, Kadoma, Osaka, Japan
[8] Kodama Clin, Nishinomiya, Hyogo, Japan
[9] Shimonagata Clin, Nishinomiya, Hyogo, Japan
[10] Kobayashi Clin, Sakai, Osaka, Japan
[11] Ohta Clin, Mino, Japan
[12] Horiguchi Clin, Ikeda, Osaka, Japan
[13] Ebisuno Clin, Izumiotsu, Japan
[14] Katsube Clin, Nishinomiya, Hyogo, Japan
[15] Univ Tokyo, Dept Clin Epidemiol & Syst, Tokyo, Japan
[16] Univ Tokyo, Dept Clin Trial Data Management, Tokyo, Japan
关键词
angiotensin receptor blocker; atherosclerosis; calcium channel blocker; diastolic dysfunction; INTIMA-MEDIA THICKNESS; BRAIN NATRIURETIC PEPTIDE; CAROTID-ARTERY INTIMA; HEART-FAILURE; EJECTION FRACTION; MYOCARDIAL FIBROSIS; RENAL-INSUFFICIENCY; CARDIOVASCULAR RISK; RECEPTOR BLOCKADE; RENIN-ANGIOTENSIN;
D O I
10.1038/hr.2010.237
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
This study was a prospective, randomized, open, blinded endpoint study to assess the effects of angiotensin II type 1 receptor blocker, losartan, compared with calcium channel blocker, amlodipine, on left ventricular (LV) diastolic function and atherosclerosis of the carotid artery in Japanese patients with mild-to-moderate hypertension, LV hypertrophy, diastolic dysfunction and preserved systolic function. Fifty-seven patients were randomly assigned to losartan-or amlodipine-based treatment groups and were followed up for 18 months. Blood pressure was similarly reduced by both regimens. Losartan shortened the transmitral E-wave deceleration time, and amlodipine reduced LV mass index; however, there was no significant difference in the percent changes of these indices between the two groups. Mean carotid intima-media thickness (mean IMT) as well as plaque score significantly increased in the amlodipine-based regimen (pre: 1.05 +/- 0.26 mm, follow-up: 1.23 +/- 0.33 mm, P=0.0015), but not in the losartan-based regimen (pre: 1.08 +/- 0.35 mm, follow-up: 1.16 +/- 0.52 mm, P non-significant). The percent increase in mean IMT in the amlodipine-based regimen tended to be large compared with the losartan-based regimen (amlodipine: 19.8 +/- 23.7%, losartan: 6.9 +/- 23.3%, P=0.06). Under similar reduction of blood pressure, losartan is likely effective in protecting the progression of atherosclerosis of the carotid artery compared with amlodipine. Losartan may improve LV diastolic function, and amlodipine may attenuate LV hypertrophy; however, this study cannot make consecutive remarks about the superiority of either treatment regimen in the effects on cardiac function and geometry. This study has been registered at http://www.umin.ac.jp/ctr/listj/(identifier C000000319). Hypertension Research (2011) 34, 325-330; doi:10.1038/hr.2010.237; published online 2 December 2010
引用
收藏
页码:325 / 330
页数:6
相关论文
共 40 条
[1]   Predictive value of systolic and diastolic function for incident congestive heart failure in the elderly: The Cardiovascular Health Study [J].
Aurigemma, GP ;
Gottdiener, JS ;
Shemanski, L ;
Gardin, J ;
Kitzman, D .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2001, 37 (04) :1042-1048
[2]   Mitral ratio of peak early to late diastolic filling velocity as a predictor of mortality in middle-aged and elderly adults - The strong heart study [J].
Bella, JN ;
Palmieri, V ;
Roman, MJ ;
Liu, JE ;
Welty, TK ;
Lee, ET ;
Fabsitz, RR ;
Howard, BV ;
Devereux, RB .
CIRCULATION, 2002, 105 (16) :1928-1933
[3]  
CHOBANIAN AV, 2003, JAMA-J AM MED ASSOC, V289, P2560, DOI DOI 10.1161/01.HYP.0000107251.49515.C2
[4]   Different effects of antihypertensive therapies based on losartan or atenolol on ultrasound and biochemical markers of myocardial fibrosis -: Results of a randomized trial [J].
Ciulla, MM ;
Paliotti, R ;
Esposito, A ;
Diez, J ;
López, BA ;
Dahlóf, B ;
Nicholls, G ;
Smith, RD ;
Gilles, L ;
Magrini, F ;
Zanchetti, A .
CIRCULATION, 2004, 110 (05) :552-557
[5]   Effects of losartan and atenolol on left ventricular mass and neurohormonal profile in patients with essential hypertension and left ventricular hypertrophy [J].
Dahlof, B ;
Zanchetti, A ;
Diez, J ;
Nicholls, MG ;
Yu, CM ;
Barrios, V ;
Aurup, P ;
Smith, RD ;
Johansson, M .
JOURNAL OF HYPERTENSION, 2002, 20 (09) :1855-1864
[6]   Regression of hypertensive left ventricular hypertrophy by losartan compared with atenolol -: The Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) trial [J].
Devereux, RB ;
Dahlöf, B ;
Gerdts, E ;
Boman, K ;
Nieminen, MS ;
Papademetriou, V ;
Rokkedal, J ;
Harris, KE ;
Edelman, JM ;
Wachtell, K .
CIRCULATION, 2004, 110 (11) :1456-1462
[7]   ECHOCARDIOGRAPHIC ASSESSMENT OF LEFT-VENTRICULAR HYPERTROPHY - COMPARISON TO NECROPSY FINDINGS [J].
DEVEREUX, RB ;
ALONSO, DR ;
LUTAS, EM ;
GOTTLIEB, GJ ;
CAMPO, E ;
SACHS, I ;
REICHEK, N .
AMERICAN JOURNAL OF CARDIOLOGY, 1986, 57 (06) :450-458
[8]   Losartan-dependent regression of myocardial fibrosis is associated with reduction of left ventricular chamber stiffness in hypertensive patients [J].
Díez, J ;
Querejeta, R ;
López, B ;
González, A ;
Larman, M ;
Ubago, JLM .
CIRCULATION, 2002, 105 (21) :2512-2517
[9]   Arterial stiffness is associated with regional ventricular systolic and diastolic dysfunction - The multi-ethnic study of atherosclerosis [J].
Fernandes, Veronica Rolim S. ;
Polak, Joseph F. ;
Cheng, Susan ;
Rosen, Boaz D. ;
Carvalho, Benilton ;
Nasir, Khurram ;
McClelland, Robyn ;
Hundley, Gregory ;
Pearson, Greg ;
O'Leary, Daniel H. ;
Bluemke, David A. ;
Lima, Joao A. C. .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2008, 28 (01) :194-201
[10]   Uric acid: A marker of increased cardiovascular risk [J].
Gagliardi, Ana C. M. ;
Miname, Marcio H. ;
Santos, Raul D. .
ATHEROSCLEROSIS, 2009, 202 (01) :11-17